Antifungal Prophylaxis Is Effective against Murine Invasive Pulmonary Aspergillosis | Zendy

Günter Rieg | Zendy; Brad Spellberg | Zendy; Julie Schwartz | Zendy; Yue Fu | Zendy; John E. Edwards | Zendy; Donald C. Sheppard | Zendy; Ashraf S. Ibrahim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antifungal Prophylaxis Is Effective against Murine Invasive Pulmonary Aspergillosis

Author(s) -

Günter Rieg,

Brad Spellberg,

Julie Schwartz,

Yue Fu,

John E. Edwards,

Donald C. Sheppard,

Ashraf S. Ibrahim

Publication year - 2006

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00299-06

Subject(s) - antifungal , aspergillosis , medicine , echinocandins , pulmonary aspergillosis , intensive care medicine , mycosis , voriconazole , immunology , caspofungin , dermatology

Antifungal prophylaxis for patients at high risk for aspergillosis is appealing due to the high morbidity and mortality of aspergillosis despite antifungal therapy ([1][1]-[3][2]). While voriconazole is a logical option, reports of breakthrough mucormycosis are a cause for concern ([5][3]). To

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research